Literature DB >> 17497488

Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK).

Mette Brekke1, Magne Rekdal, Jørund Straand.   

Abstract

OBJECTIVE: To assess level of cardiovascular risk factors in a non-selected, middle-aged population. To estimate the proportion target for risk intervention according to present guidelines and according to different cut-off levels for two risk algorithms.
DESIGN: Population survey, modelling study.
SETTING: The Norwegian Hordaland Health Study (HUSK) 1997-99.
SUBJECTS: A total of 22 289 persons born in 1950-57. MAIN OUTCOME MEASURES: Own and relatives' cardiovascular morbidity, antihypertensive and lipid-lowering treatment, smoking, blood pressure, cholesterol. Framingham and Systematic Coronary Risk Evaluation (SCORE) algorithms. The European guidelines on CVD prevention in clinical practice were applied to estimate size of risk groups.
RESULTS: Some 9.7% of men and 7.6% of women had CVD, diabetes mellitus, a high level of one specific risk factor, or received lipid-lowering or antihypertensive treatment. Applying a SCORE (60 years) cut-off level at 5% to the rest of the population selected 52.4% of men and 0.8% of women into a primary prevention group, while a cut-off level at 8% included 22.0% and 0.06% respectively. A cut-off level for the Framingham score (60 years) of 20% selected 43.6% of men and 4.7% of women, while a cut-off level of 25% selected 25.6% of men and 1.8% of women.
CONCLUSION: The findings illustrate how choices regarding risk estimation highly affect the size of the target population. Modelling studies are important when preparing guidelines, to address implications for resource allocation and risk of medicalization. The population share to be targeted for primary prevention ought to be estimated, including the impact of various cut-off points for risk algorithms on the size of the risk population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497488      PMCID: PMC3379744          DOI: 10.1080/02813430701241087

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  29 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 2.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

3.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

4.  Variations and increase in use of statins across Europe: data from administrative databases.

Authors:  Tom Walley; Pietro Folino-Gallo; Ulrich Schwabe; Eric van Ganse
Journal:  BMJ       Date:  2004-02-14

5.  Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

6.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; M Mähönen; H Tolonen; E Ruokokoski; P Amouyel
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

7.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

8.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

9.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

10.  Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Authors:  Peter Brindle; Jonathan Emberson; Fiona Lampe; Mary Walker; Peter Whincup; Tom Fahey; Shah Ebrahim
Journal:  BMJ       Date:  2003-11-29
View more
  6 in total

1.  When do adolescents become smokers? Annual seven-year population-based follow-up of tobacco habits among 2000 Swedish pupils--an open cohort study.

Authors:  Ingrid Edvardsson; Lena Lendahls; Anders Håkansson
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

2.  Secular trends in cardiovascular risk factors with a 36-year perspective: observations from 38- and 50-year-olds in the Population Study of Women in Gothenburg.

Authors:  Cecilia Björkelund; Dominique Andersson-Hange; Kate Andersson; Calle Bengtsson; Ann Blomstrand; Dorota Bondyr-Carlsson; Gabriele Eiben; Kerstin Rödström; Agneta Sjöberg; Valter Sundh; Lilian Weman; Dimitri Zylberstein; Magnus Hakeberg; Lauren Lissner
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

3.  Did a health dialogue matter? Self-reported cardiovascular disease and diabetes 11 years after health screening.

Authors:  Lisbeth Färnkvist; Niclas Olofsson; Lars Weinehall
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

4.  Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice.

Authors:  Dea Kehler; Morten Bondo Christensen; Mette Bech Risør; Torsten Lauritzen; Bo Christensen
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

5.  Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observational study.

Authors:  Mette Brekke; Jørund Straand
Journal:  BMC Public Health       Date:  2011-03-02       Impact factor: 3.295

6.  Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: lessons learned from a health care services study.

Authors:  Theodora Zachariadou; Henri E J H Stoffers; Costas A Christophi; Anastasios Philalithis; Christos Lionis
Journal:  BMC Health Serv Res       Date:  2008-07-16       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.